Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravesical Alkalinized Lidocaine-Heparin for the Symptoms of Pelvic Pain and/or Urgency of Bladder Origin

NCT00256542 is registered in ClinicalTrials.gov with Urigen as lead sponsor.

NCT NCT00256542
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00256542 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intravesical Alkalinized Lidocaine-Heparin for the Symptoms of Pelvic Pain and/or Urgency of Bladder Origin
Lead sponsor
Urigen
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2006
Completion date
September 30, 2006
Enrollment
90
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

bladder diseases, interstitial cystitis, pelvic pain